Regulation (EU) No 1027/2012 of the European Parliament and of the Council of 25 October 2012 amending Regulation (EC) No 726/2004 as regards pharmacovigilance
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD) Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XIII Medicinal Products
Joint committee decision (JCD)
163/2013 In force in the EEA
Yes Legal documents
Regulation (EU) No 1027/2012 of the European Parliament and of the Council of 25 October 2012 amending Regulation (EC) No 726/2004 as regards pharmacovigilance
Reglugerð Evrópuþingsins og ráðsins (ESB) nr. 1027/2012 frá 25. október 2012 um breytingu á reglugerð (EB) nr. 726/2004 að því er varðar lyfjagát
Verordnung (EU) Nr. 1027/2012 des Europäischen Parlaments und des Rates vom 25. Oktober 2012 zur Änderung der Verordnung (EG) Nr. 726/2004 hinsichtlich der Pharmakovigilanz
Europaparlaments- og rådsforordning nr. 1027/2012 av 25. oktober 2012 om endring av forordning nr. 726/2004 med hensyn til legemiddelovervåking
History
28.05.2014
Adopted JCD confirmed entry into force date
28.05.2014
Compliance date in the EEA
08.10.2013
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
17.06.2013
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
25.11.2012
Adoption date in the EU
12.12.2012
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.